FDA Approves Jascayd for Progressive Pulmonary Fibrosis

TUESDAY, Dec. 30, 2025-- The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults.Jascayd becomes the first and only preferential phosphodiesterase 4B...